Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to give their agreement to take part before enrolling in the registry (for children or those unable to give consent themselves, a parent or legal guardian must also give their agreement)
- People who received a confirmed cancer diagnosis of any type within the 15 years before the trial site began operating
- People who were aged between 0 and 21 years old at the time of their cancer diagnosis
- People who received meaningful cancer treatment at the participating centre, such as chemotherapy, surgery, radiation therapy, or immunotherapy
- People whose medical records are available and can be reviewed by the research team
Who may not be able to join:
- People who only visited the participating centre for a consultation, without going on to receive their main cancer treatment there
- People who only attended the participating centre for tests such as pathology or radiology, without receiving any cancer treatment there
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +1-901-205-9518
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To estimate the incidence of treatment failure, in patients with any type of cancer diagnosis.; To estimate the incidence of therapy related toxicities in patients diagnosed with acute lymphoblastic leukemia or lymphoblastic lymphoma.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.